| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/31/2004 | EP0777484B1 Intravenous alendronate formulations |
| 03/31/2004 | EP0744951B1 Process for producing a sterile prednisolone gel |
| 03/31/2004 | CN1486327A 载脂蛋白类似物 Apolipoprotein analogues |
| 03/31/2004 | CN1486313A Compounds for use in the treatment of skin conditions |
| 03/31/2004 | CN1486196A Complex of modafinil and cyclodextrin |
| 03/31/2004 | CN1486191A Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 03/31/2004 | CN1486188A Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 03/31/2004 | CN1486187A L-histidine in ophthalmic solutions |
| 03/31/2004 | CN1486186A Improved ophthalmic and contact lens solutions containing forms of vitamin B |
| 03/31/2004 | CN1486185A Stabilized brivudine topical formulations containing metal oxide pigments |
| 03/31/2004 | CN1486179A Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 03/31/2004 | CN1486177A Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 03/31/2004 | CN1485095A Preparation process of the freeze drying protective agent for the vaccin used for animals |
| 03/31/2004 | CN1485094A Natural porous polymer beads, the preparation and application thereof |
| 03/31/2004 | CN1143859C Camptothecin derivative and its preparation |
| 03/31/2004 | CN1143689C Aqueous coated composition and method for preparing solid medicine formulation |
| 03/31/2004 | CN1143688C Triacetin as transdermal permeation enhancer |
| 03/31/2004 | CN1143680C Method of enhancing bioavailability of fexofenadine and its derivatives |
| 03/31/2004 | CN1143673C Improvement in the taste of active pharmaceutical ingredients |
| 03/31/2004 | CN1143672C Pharmaceutical compositions comprising uridine triphosphate |
| 03/31/2004 | CN1143668C Ascorbyl-phosphoryl-cholesterol |
| 03/30/2004 | US6713616 Detecting binding |
| 03/30/2004 | US6713606 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 03/30/2004 | US6713533 Nanocapsules and method of production thereof |
| 03/30/2004 | US6713461 Eletriptan and sulphobutylether-beta-cyclodextrin; well tolerated intranasal delivery; bioavailability; fast acting |
| 03/30/2004 | US6713454 Prodrugs of etoposide and etoposide analogs |
| 03/30/2004 | US6713453 Sustained release; drug delivery; tissue adhesive |
| 03/30/2004 | US6713452 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 03/30/2004 | US6713095 Heating and adding a tocotrienol/tocopherol blend and rosmarinic acid and polyphenols |
| 03/30/2004 | US6713090 Apparatus and method for preparing microparticles |
| 03/30/2004 | US6713089 Under acidic conditions; nonsteroid antiinflammatory nsaid; crushing strength |
| 03/30/2004 | US6713079 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from l-arganine analog, dextran, heparin, cysteine and cystine |
| 03/30/2004 | US6713048 Δ9 tetrahydrocannabinol (Δ9 THC) solution metered dose inhalers and methods of use |
| 03/30/2004 | US6713047 Mixture of hfa 134a and hfa 227 allows modulation of the mass median aerodynamic diameter (mmad) of the aerosol particles to target specific regions of the repiratory tract |
| 03/30/2004 | US6713042 Ascorbic acid analogs for metalloradiopharmaceuticals |
| 03/30/2004 | CA2339073C Composition for suppressing cellular fibrousing and method for preparing an extract from loquat seeds |
| 03/30/2004 | CA2304110C Theophylline sustained release tablet |
| 03/30/2004 | CA2201611C Saponin preparations and use thereof in iscoms |
| 03/30/2004 | CA2178602C Microcapsules, method of making and their use |
| 03/30/2004 | CA2162993C Solid fat nanoemulsions as drug delivery vehicles |
| 03/30/2004 | CA2152907C Antiviral topical pharmaceutical compositions |
| 03/30/2004 | CA2148043C Solid pharmaceutical dosage form containing flavored film coating |
| 03/30/2004 | CA2127805C Composition for nasal administration |
| 03/30/2004 | CA2122922C Method and composition for treating tumors having high tyrosinase activity |
| 03/30/2004 | CA2109065C Bioartificial endocrine device |
| 03/25/2004 | WO2004025263A2 Protein and peptide expression for passive immunity |
| 03/25/2004 | WO2004024909A2 Recombinant colstridium neurotoxin fragments |
| 03/25/2004 | WO2004024889A2 Production of bispecific molecules using polyethylene glycol linkers |
| 03/25/2004 | WO2004024777A1 Hydroxyalkyl starch derivatives |
| 03/25/2004 | WO2004024776A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | WO2004024761A1 Hasylated polypeptides, especially hasylated erythropoietin |
| 03/25/2004 | WO2004024695A1 Novel molecules derived from noraporphine |
| 03/25/2004 | WO2004024226A1 Device for delivering a viscous medical solution to the nasal membrane and method for using same |
| 03/25/2004 | WO2004024225A1 System and method for delivering a composition to the nasal membrane |
| 03/25/2004 | WO2004024197A1 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 03/25/2004 | WO2004024189A1 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/25/2004 | WO2004024188A1 Preparation for controlling binging of drug to plasma protein |
| 03/25/2004 | WO2004024187A2 Compositions to reduce congestion and methods for application thereof to the nasal membrane |
| 03/25/2004 | WO2004024168A1 Composition and method for use in intestinal cleansing procedures |
| 03/25/2004 | WO2004024164A1 Stable eye drops containing latanoprost as the active ingredient |
| 03/25/2004 | WO2004024152A1 Stable cream preparations of phenyl-pyridone compounds for topical application |
| 03/25/2004 | WO2004024138A1 Solid preparation containing dioctyl sodium sulfosuccinate |
| 03/25/2004 | WO2004024128A2 Modified release ketoprofen dosage form |
| 03/25/2004 | WO2004024122A1 Composition and method for moisturizing nasal tissue |
| 03/25/2004 | WO2004024057A1 Process for producing seamless capsule quickly dissolving in the oral cavity |
| 03/25/2004 | WO2004023899A1 Human and/or animal fiber-water including encapsulated additives having specific dietary and medical uses |
| 03/25/2004 | WO2004018511A3 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/25/2004 | WO2004006954A3 Transdermal botulinum toxin compositions |
| 03/25/2004 | WO2004005237B1 Method of preparing hydroxytyrosol esters, esters thus obtained and use of same |
| 03/25/2004 | WO2004000358B1 Transdermal drug delivery system |
| 03/25/2004 | WO2003105826B1 "soluble stable pharmaceutical composition for the administration of hiv protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of hiv protease inhibitors." |
| 03/25/2004 | WO2003103822A3 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 03/25/2004 | WO2003103681A3 Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema |
| 03/25/2004 | WO2003103603A3 Novel formate salt of o-desmethyl-venlafaxine |
| 03/25/2004 | WO2003094842A3 Conjugates comprising central nervous system active drug |
| 03/25/2004 | WO2003092735A3 Peptide nucleic acid conjugates with beta-amino acid polymers or reptoids |
| 03/25/2004 | WO2003092640A3 Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 03/25/2004 | WO2003090726A3 Chewable soft capsule |
| 03/25/2004 | WO2003086392A3 Process for preparing a finely self-emulsifiable pharmaceutical composition |
| 03/25/2004 | WO2003086318A3 Improved prodrugs of cc-1065 analogs |
| 03/25/2004 | WO2003084926A3 Polymeric acyl derivatives of indoles |
| 03/25/2004 | WO2003077842A3 Palatable oral suspension and method |
| 03/25/2004 | WO2003076472A3 Neoplasm specific antibodies and uses thereof |
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003074551A3 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 03/25/2004 | WO2003072195A3 Method for administering glp-1 molecules |
| 03/25/2004 | WO2003072060A3 Polypeptide formulation |
| 03/25/2004 | WO2003070884A3 RNA INTERFERENCE MEDIATED INHIBITION OF MDR P-GLYCOPROTEIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/25/2004 | WO2003066104A3 Pharmaceutical composition which improves in vivo gene transfer |
| 03/25/2004 | WO2003047567A8 STABLE, ACID, AQUEOUS SOLUTION CONTAINING α-LIPONIC ACID (DERIVATIVES), METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME |
| 03/25/2004 | WO2003031475A3 Antibodies against kdr, their production and uses |
| 03/25/2004 | WO2003015612A3 Materials and methods to promote repair of nerve tissue |
| 03/25/2004 | WO2003011008A3 Therapeutic delivery compositions and methods of use thereof |
| 03/25/2004 | WO2003006501A3 G-csf conjugates |
| 03/25/2004 | WO2002076394A3 Enzyme-based anti-cancer compositions and methods |
| 03/25/2004 | WO2002002095B1 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 03/25/2004 | US20040059094 Hapten-carrier conjugates and uses thereof |
| 03/25/2004 | US20040059066 Injections for endoscopy |
| 03/25/2004 | US20040059025 Activation, water solubility; complex of polyoxyalkylene glycol and protein, peptides, enzymes, drugs |
| 03/25/2004 | US20040059001 Extended release pharmaceutical composition containing metformin |